Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : Astellas Receive Positive Opinion From European Medicines Agency for Xtandi

03/26/2021 | 08:58am EDT


ę MT Newswires 2021
All news about PFIZER, INC.
05:32pPFIZER : Israel to give Pfizer COVID-19 booster to 60 and over as Delta spreads
AQ
04:42pPFIZER : Israel to offer 3rd COVID booster shot to older citizens
AQ
02:08pPFIZER : Israel approves Pfizer booster shot for over 60sá
AQ
01:15pExclusive - AstraZeneca exploring options for COVID-19 vaccine business - exe..
RE
12:06pJOHNSON & JOHNSON : SA to Soon Administer Over 300,000 Covid-19 Vaccines a Day
AQ
12:05pAstraZeneca COVID-19 sales jump as drugmaker navigates vaccine challenges
RE
11:50aPFIZER : Goldman Sachs Adjusts Pfizer's Price Target to $48 From $44, Maintains ..
MT
11:48aPFIZER : SVB Leerink Adjusts Price Target on Pfizer to $49 From $47, Maintains M..
MT
11:47aPFIZER : Morgan Stanley Adjusts Price Target on Pfizer to $45 From $42, Maintain..
MT
10:51aPFIZER INC : Goldman Sachs gives a Neutral rating
MD
More news
Financials (USD)
Sales 2021 77 467 M - -
Net income 2021 17 986 M - -
Net Debt 2021 30 021 M - -
P/E ratio 2021 12,4x
Yield 2021 3,70%
Capitalization 240 B 240 B -
EV / Sales 2021 3,48x
EV / Sales 2022 4,12x
Nbr of Employees 78 500
Free-Float 59,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Last Close Price 42,79 $
Average target price 43,07 $
Spread / Average Target 0,65%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.16.25%243 220
JOHNSON & JOHNSON9.40%453 418
ROCHE HOLDING AG12.49%332 374
ELI LILLY AND COMPANY46.00%224 084
NOVARTIS AG0.39%223 750
ABBVIE INC.10.64%209 386